Member Info for BuenaVista

Just a reminder that Thornogson/NDN/Eggy works for Tom Winnifrith and isn't invested, just says he holds Avacta shares, which anyone can say without proof.

All those biopharma mini-caps hawking their wares... Is it any wonder big farmer deliberates long and hard over where to invest its cash?

I see that Tempus AI are there, Monday 13:30.

Philogen/Philochem not presenting, unless I missed them.

Just a reminder that the ToucanOFDoom is an idiot, because only an idiot would believe that counter arguments to 'optimistic predictions' are made-up pessimistic predictions, not facts.

US government funding runs out on 30 January. If the farce of October last year is repeated, the FDA will close down again until a compromise can be reached.

Just a reminder that wyndrum isn't invested - and is only here to disrupt and sow discord and is not in the slightest interested in understanding or learning about the science.

@Bella, there were two other IMC webinars that day, one at 10am and the other at 1pm, both of them under an hour long so, barring cancellations, I doubt lack of available slots was the reason.

https://www.investormeetcompany.com/archived-meetings

@Bella, the AIM traders are only interested in short-term funding, not the long-term benefits of the science and that 17 December presentation was billed and was about the science. I do think though that CC coud at least mention the potential TAM for AVA6103, and particularly AVA6000, indications.

@Thompi, good point picking out the angry ToucanOfDoom's imbecilic comment.

The timing of the 17 December presentation was very odd I thought. 10am London time. So obviously not arranged for people in the US - why not? They could of course listen to the recording later but they would not have been able to ask questions during the actual presentation (fat lot of use that that is) unless they were up at silly o'clock.

It was also unclear where CC and DL were, whether either of them were in London or at home. If they were at home, 10am for us would be a 5am presentation start for CC and 2am for DL. That could explain the downbeat presentation but it comes back to WHY a 10am GMT start? Quite bizarre.

Just a reminder that wyndrum isn't invested - and is only here to disrupt and and sow discord.

Just a reminder that wyndrum isn't invested.

They'll be buying US oil stocks you mean.

Well let's hope she reads this and uses an egg and some wipes next time.

The FDA's ODD was for STS.

Absolutely VS. Granted US patent valid until 15 June 2035, filed when AVA6000 was called 3099DOX: https://patents.google.com/patent/US9737556B2/en

PDF of the US patent: https://patentimages.storage.googleapis.com/9e/f0/c7/8edbda02211a3e/US9737556.pdf

The Written Opinion reduced the claims to "The subject-matter of claims 48-50 and 87 therefore meet the requirements of the PCT with respect to novelty and inventive step."

48. The compound of claim 1, wherein the compound is selected from those in Table 4, and pharmaceutically acceptable salts thereof.

49. A compound, wherein the compound is selected from those in Table 5B, and pharmaceutically acceptable salts thereof.

50. A construct, or a pharmaceutically acceptable salt thereof, comprising a compound selected from those in Table 5B, or a pharmaceutically acceptable salt thereof, conjugated to a binding moiety.

87. The construct of claim 11, wherein the construct is selected from those in Table 5A.

- - - - -

Here's hoping that AVA6103 is amongst these allowed compounds! It is normal to make very broad claims as well as for what you want to specifically cover. The broader the claims that are accepted, the better the protection, but it's usual for many of them to be rejected. That's not such a bad thing - and is integral to why broad claims are made - as all the compounds described in the application, whether ultimately allowed or not, are now in the public domain and so have lost 'novelty', which will therefore bar other companies from working in those areas.

- - - - -

Who'd be a patent agent, patent examiner, or patent attorney, eh?!

Is Unicorno HurstBot with an inbuilt AI module?

Unicorno's AI wrote: "The publication of this patent on January 2nd is a clear tactical signal. ... With exactly 10 days until the J.P. Morgan Healthcare Conference begins on January 12th, Avacta has presented the market (and potential partners) with the final legal proof they need to sign a binding offer."

This implies that Avacta dictated when the World Intellectual Property Organisation should publish the patent.

🤣🤣🤣

No, what I actually wrote - and I will put it in quotes, like how you misquoted me - was "Note that the patents published today are patent applications, not legally enforceable granted patents."

If you want some real FUD, I would hazard a guess that no company would enter an agreement with Avacta based just on patent applications without the surety of having the invention(s) fully protected by granted IP. It will take a while for the patent applications to be examined and potentially challenged - there is always the provision for that to be done prior to granting a patent. Of course, clauses could be written into any agreement that would up the value if/when IP protection is granted.

https://www.google.com/search?q=can+a+patent+application+be+challenged+before+granting

Just a reminder that Thornogson/NDN/Eggy isn't invested and works for Tom Winnifrith.

Re "By securing this patent, Avacta has legally locked down the ability to deliver Exatecan—the same high-potency payload used in blockbuster drugs like Enhertu—using their safe, tumor-targeted "masking" system. This patent allows Avacta to expand from SGC and Sarcoma into massive "blockbuster" markets like Pancreatic, Gastric, and Triple Negative Breast Cancer (TNBC), which are highly sensitive to Topo inhibitors."

Note that the patents published today are patent applications, not legally enforceable granted patents.